HALO logo
halo search icon
Annovis Bio Inc

US$2.04

Price Change Indicator
0.10 (5.16%)
Annovis Bio Inc
ANVS · NYS

Annovis Bio Inc

Start Trading ANVS for Free

US$2.04

Price Arrow0.10 (5.16%)
20/05/2026 04:10:00 PM
All-CompaniesAll-ConsensusBig Candle (Realtime)Engulfing BullishHALO AllHALO Consensus Value
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Annovis Bio Inc Overview

ANVS Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Weak

Earnings

Neutral

Growth

Earnings

Neutral

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About ANVS

icon
icon

Telephone

1.484.875.3192

icon

Address

Suite 225, 101 Lindenwood Drive, Malvern, PA 19355

Description

Annovis Bio, Inc. is a clinical stage drug platform company, which engages in the development of drugs aiming to treat neurodegenerative diseases, such as Alzheimer's (AD) and Parkinson's (PD). Its lead product candidate, Buntanetap, is designed to address AD, PD, and potentially other chronic neurodegenerative diseases. The company's product pipeline also includes ANVS405 and ANVS301, which focus on the treatment of traumatic brain injury, stroke, and advanced AD. Annovis Bio was founded by Maria Luisa Maccecchini in May 2008 and is headquartered in Malvern, PA.

ANVS Price Chart

Key Stats

Market Cap

US$67.21M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 1.54 - 5.5

Trade Value (12mth)

US$610,718.00

1 week

-5.83%

1 month

4.3%

YTD

-46.85%

1 year

-3.48%

All time high

132.00

Key Fundamentals

EPS 3 yr Growth

-54.80%

EBITDA Margin

0.00%

Operating Cashflow

-$26m

Free Cash Flow Return

-195.90%

ROIC

-220.60%

Interest Coverage

0.00

Quick Ratio

5.80

Other Data

Shares Outstanding (Fully Diluted)

28m

HALO Sector

Healthcare

Next Company Report Date

15-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

ANVS Announcements

Latest Announcements

DateAnnouncements
21 May 26
21 May 26
21 May 26
20 May 26
16 May 26

ANVS Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-6.23-2.02-1.4locklocklock
EPS (Fully Diluted)
 $locklocklocklock-6.23-2.31-1.4locklocklock
Growth
 %locklocklocklock-100.767.630.4locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Annovis Bio Inc (ANVS:NYS)?
Halo FAQ
The current share price of Annovis Bio Inc (ANVS:NYS) is USD$2.04.
What is the 52-week high share price for Annovis Bio Inc (ANVS:NYS)?
Halo FAQ
The 52-week high share price for Annovis Bio Inc (ANVS:NYS) is USD$5.50.
What is the 52-week low share price for Annovis Bio Inc (ANVS:NYS)?
Halo FAQ
The 52-week low share price for Annovis Bio Inc (ANVS:NYS) is USD$1.54.
What is the dividend yield for Annovis Bio Inc (ANVS:NYS)?
Halo FAQ
Annovis Bio Inc (ANVS:NYS) does not pay a dividend.
What was Annovis Bio Inc (ANVS:NYS) last dividend payment?
Halo FAQ
Annovis Bio Inc (ANVS:NYS) does not pay a dividend.
What is the franking level for Annovis Bio Inc (ANVS:NYS)?
Halo FAQ
Annovis Bio Inc (ANVS:NYS) has a franking level of 0.00%.
In which sector is Annovis Bio Inc (ANVS:NYS) classified?
Halo FAQ
Annovis Bio Inc (ANVS:NYS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial